Allurion Technologies, Inc. Warrants, each whole warrant exerci — Quarterly Financial Statistics (NYSE:ALUR-WT) | MetaTrader

Open full chart

Financials

Overview Finanzbericht Statistics Dividends

Quarterly Annual

Cash from operating activities 11.44 M13.3 M9.5 M7.6 M6.5 M 36.9 M Cash from investing activities 72 K0104 K435 K72 K — Cash from financing activities 19.59 M-53 K14.5 M-71 K-55 K 14.32 M Free cash flow 11.37 M13.3 M9.5 M7.6 M6.5 M 36.9 M

Nachrichten

Are Medical Stocks Lagging Allurion Technologies, Inc. (ALUR) This Year?

What's Going On With Allurion Stock On Wednesday? - Allurion Technologies (NYSE:ALUR)

Allurion-Aktie: Hochstufung auf „Buy“ nach FDA-Zulassung

Allurion Technologies stock rating upgraded on FDA approval

FDA-Zulassung für Magenballon: Allurion-Aktie schießt um 40 % in die Höhe

FDA approves Allurion gastric balloon for obesity treatment

Allurion stock surges 40% on U.S. FDA approval

Tracking Saudi Sovereign Wealth Fund’s 13F Portfolio – Q3 2025 Update

Allurion Technologies (ALUR) director sells $4.9k in shares

Allurion reports 23% weight loss combining balloon with low-dose GLP-1

Allurion Smart Capsule shows 20% weight reduction in new study

Zacks Industry Outlook Highlights Boston Scientific, Insulet, BioLife Solutions and Allurion